Drug Type Small molecule drug |
Synonyms MK-5596 |
Target |
Mechanism CB1 inverse agonists(Cannabinoid CB1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H23Cl3N4O2 |
InChIKeyIDUFEEHNNASCMH-HSZRJFAPSA-N |
CAS Registry1044586-68-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | US | 27 May 2010 |